Vishal Mega Mart grants 9.75 lakh stock options at Rs. 119
Vishal Mega Mart Limited granted 9,75,000 stock options to employees at Rs. 119 per option under ESOP 2019. The options convert into equity shares of Rs. 10 face value each. The exercise period is 10 years from the grant date.

*this image is generated using AI for illustrative purposes only.
Vishal Mega Mart has granted 9,75,000 stock options to eligible employees under the Vishal Mega Mart Employees Stock Options Plan 2019. The Nomination and Remuneration Committee of the Board of Directors approved the grant on June 15, 2026, through circulation. The exercise price for these options is set at Rs. 119 per option.
The grant is compliant with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Each stock option granted is convertible into one fully paid-up equity share with a face value of Rs. 10. Consequently, the total number of equity shares covered by these options stands at 9,75,000.
The exercise period for the vested options is 10 years from the date of grant, unless the Board or the Committee decides otherwise. The company stated that the disclosure is made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Details of ESOP Grant
| Parameter | Details |
|---|---|
| Total Options Granted | 9,75,000 |
| Exercise Price | Rs. 119 per option |
| Face Value per Share | Rs. 10 |
| Exercise Period | 10 years from date of grant |
| Options Vested | Not applicable (grant stage) |
The intimation regarding this grant has been submitted to the National Stock Exchange of India Ltd. and BSE Limited. The information will also be hosted on the company's website.
Historical Stock Returns for Vishal Mega Mart
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.56% | +0.43% | -0.18% | -12.67% | -4.87% | +6.11% |
How will the issuance of these 9.75 lakh new shares impact the company's earnings per share (EPS) upon conversion?
What is the expected vesting schedule for these options, and when might the dilution actually occur?
Does this grant signal a shift in the company's retention strategy ahead of its potential IPO or expansion plans?


































